Igor Siegfried

Doctor of Medicine,  Massachusetts General Hospital 

Location: United States

Consulting Services

Case Consulting Journal Manuscript Sales and Marketing

Areas Of Interest

Cyclin, Type C Performances, Job Cockroaches, American Nuclear Sizes, Cell Disomy, Uniparental Pea Plants, Pigeon Margins, Costal Common Data Element Demineralization, Tooth Hereditary Sensory and Autonomic Neuropathy Type II Crosslinking Reagents Oral Contraceptives, Low Dose Cefonicid Monosodium Salt Villus, Placental Infection, Anisakis Drink, Sugar-Sweetened Soft Calcium Saccharate Regions, Matrix-Attached Oreochromis niloticus Ribonuclease (Pancreatic) Cysts, Hydatid Dilevalol Cancer of Duodenum Dystonia Musculorum Deformans Caulimoviruses Remestyp Clinical Trials, Phase II as Topic Peritoneo-Venous Shunt Procedure, Obstetrical Surgical Cell, Squamous Epithelial Obesity, Adolescent Whistleblowers Cell Death, Pyroptotic Ligaments, Flaval Sex Cord-Stromal Tumor Cyclase, Adenylate Deficiencies, PCC Torulopsis glabrata Pulmonary Hypertension, Primary Salicylic Acids, 6-Alkyl

Professional Narrative

Dr. Igor Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Harvard Med 1992
Medical Writer, Mayo Clinic 1990

Education

Doctor of medicine, Perelman School of Medicine 1994
Master of Science in physician assistant, Weill Medical College 2002

Referees


Publications

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :